Pathomechanistic Networks of Motor System Injury in Amyotrophic Lateral Sclerosis

Title:Pathomechanistic Networks of Motor System Injury in Amyotrophic Lateral Sclerosis

Volume: 22 Issue: 11

Author(s): Bedaballi Dey, Arvind Kumar and Anant Bahadur Patel*

Affiliation:

• CSIR-Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad 500007, Telangana, India
• AcSIR-Academy of Scientific and Innovative Research, Ghaziabad 201002, Uttar Pradesh, India

Keywords: Amyotrophic lateral sclerosis (ALS), motor neuron disease, pathophysiology, gene environment interaction, heterogeneity, metabolism, epigenetics, RNA modification.

Abstract: Amyotrophic Lateral Sclerosis (ALS) is the most common, adult-onset, progressive motor neurodegenerative disorder that results in death within 3 years of the clinical diagnosis. Due to the clinicopathological heterogeneity, any reliable biomarkers for diagnosis or prognosis of ALS have not been identified till date. Moreover, the only three clinically approved treatments are not uniformly effective in slowing the disease progression. Over the last 15 years, there has been a rapid advancement in research on the complex pathomechanistic landscape of ALS that has opened up new avenues for successful clinical translation of targeted therapeutics. Multiple studies suggest that the age-dependent interaction of risk-associated genes with environmental factors and endogenous modifiers is critical to the multi-step process of ALS pathogenesis. In this review, we provide an updated discussion on the dysregulated cross-talk between intracellular homeostasis processes, the unique molecular networks across selectively vulnerable cell types, and the multisystemic nature of ALS pathomechanisms. Importantly, this work highlights the alteration in epigenetic and epitranscriptomic landscape due to gene-environment interactions, which have been largely overlooked in the context of ALS pathology. Finally, we suggest that precision medicine research in ALS will be largely benefitted from the stratification of patient groups based on the clinical phenotype, onset and progression, genome, exposome, and metabolic identities.

Cite this article as:

Dey Bedaballi, Kumar Arvind and Patel Bahadur Anant*, Pathomechanistic Networks of Motor System Injury in Amyotrophic Lateral Sclerosis, Current Neuropharmacology 2024; 22 (11) . https://dx.doi.org/10.2174/1570159X21666230824091601